Market Cap

Boya Bio-pharmaceutical Group Co.,Ltd Market Capitalization:

CN¥17.06 Billion

CNY as of July 1, 2024

US$2.35 Billion

business Boya Bio-pharmaceutical Group Co.,Ltd Company Profile

Boya Bio-pharmaceutical Group Co.,Ltd Main Stock Listing

SZSE: 300294

Market Capitalization History of Boya Bio-pharmaceutical Group Co.,Ltd

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $121.36 B
Regeneron Pharmaceuticals, Inc. $115.11 B
CSL Limited $95.75 B
Marinomed Biotech AG $75.67 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Boya Bio-pharmaceutical Group Co.,Ltd market cap

Date Market Cap YoY Change
Jan. 1, 2024 CN¥16.30 B -12.79%
Jan. 1, 2023 CN¥18.69 B 5.74%
Jan. 1, 2022 CN¥17.68 B 23.09%
Jan. 1, 2021 CN¥14.36 B -8.70%
Jan. 1, 2020 CN¥15.73 B 15.44%
Jan. 1, 2019 CN¥13.63 B -20.59%
Jan. 1, 2018 CN¥17.16 B -5.55%
Jan. 1, 2017 CN¥18.17 B 18.20%
Jan. 1, 2016 CN¥15.37 B 96.53%
Jan. 1, 2015 CN¥7.82 B 33.20%
Jan. 1, 2014 CN¥5.87 B 49.21%
Jan. 1, 2013 CN¥3.94 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Boya Bio-pharmaceutical Group Co.,Ltd Categories

China languages Healthcare languages Biotechnology
China Healthcare China Biotechnology

Stocks & Indices

Boya Bio-pharmaceutical Group Co.,Ltd has the following listings and related stock indices.


Stock: SZSE: 300294

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.